B401–B413 Cardiovascular/Angiogenesis

Publisher： Karger

E-ISSN： 1422-6421|166|1|102-107

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.166, Iss.1, 2000-02, pp. : 102-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A401–A406 Cardiovascular/Angiogenesis

By  

Cells Tissues Organs, Vol. 166, Iss. 1, 2000-02 ,pp. : 69-71

Karger

Access to resources Recommend Favorite

Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4899-4905

Bentham Science Publishers

Access to resources Recommend Favorite

NF-κB as a Therapeutic Target for Cardiovascular Disease

By  

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 303-311

Karger

Access to resources Recommend Favorite

The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease

By Heitsch Holger  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 5, 2003-05 ,pp. : 759-770

Informa Healthcare

Access to resources Recommend Favorite

Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion

By Denholm E.M.   Lin Y.-Q.   Silver P.J.  

European Journal of Pharmacology, Vol. 416, Iss. 3, 2001-03 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite